SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancerFei Han(First Affiliated Hospital Zhejiang University)Endocrine Related CancerJanuary 3, 201910.1530/erc-18-0529Cited by 17SaveCiteExport RISWatch citationsRelated PapersThe critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance|Nature Communications|2018|186SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer|Oncogene|2014|70TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy|Theranostics|2023|67